Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04225117
Title A Study to Evaluate Enfortumab Vedotin in Subjects With Locally Advanced or Metastatic Malignant Solid Tumors (EV-202)
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Astellas Pharma Global Development, Inc.
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | CAN

Facility Status City State Zip Country Details
Arizona Oncology Tucson Arizona 85711 United States Details
University of California - San Francisco San Francisco California 94158 United States Details
University of Colorado Aurora Colorado 80045 United States Details
Florida Cancer Specialists Fort Myers Florida 33901 United States Details
Florida Cancer Specialists Tallahassee Florida 32308 United States Details
Florida Cancer Specialists West Palm Beach Florida 33401 United States Details
Piedmont Hospital Atlanta Georgia 30318 United States Details
Northside Hospital Atlanta Georgia 30342 United States Details
Northwestern University Medical Center Chicago Illinois 60611 United States Details
University of Chicago Chicago Illinois 60637 United States Details
Indiana University Cancer Center Indianapolis Indiana 46202 United States Details
University of Kansas Fairway Kansas 66205 United States Details
Dana-Farber Cancer Institute Boston Massachusetts 02215 United States Details
University of Michigan Ann Arbor Michigan 48109 United States Details
Henry Ford Hospital Detroit Michigan 48202 United States Details
University of Minnesota Cancer Center Minneapolis Minnesota 55455 United States Details
Nebraska Methodist Hospital Omaha Nebraska 68114 United States Details
Comprehensive Cancer Centers of Nevada Las Vegas Nevada 89169 United States Details
Rutgers Cancer Institute New Brunswick New Jersey 08901 United States Details
New York University Langone Health New York New York 10016 United States Details
Memorial Sloan Kettering Cancer Center New York New York 10022 United States Details
Cleveland Clinic Cleveland Ohio 44195 United States Details
Ohio State University Columbus Ohio 43210 United States Details
Gettysburg Cancer Center Gettysburg Pennsylvania 17375 United States Details
Sarah Cannon Research Institute Nashville Tennessee 37203 United States Details
Mary Crowley Research Center Dallas Texas 75230 United States Details
University of Texas Houston Texas 77030 United States Details
Seattle Cancer Care Alliance Seattle Washington 98109 United States Details
Wisconsin Carbone Cancer Center Madison Wisconsin 53792 United States Details
Site CA15003 Ottawa Ontario K1H 8L6 Canada Details
Site JP81004 Nagoya Aichi Japan Details
Site JP81001 Kashiwa Chiba Japan Details
Site JP81005 Chuo-ku Osaka Japan Details
Site JP81007 Osaka-Sayama Osaka Japan Details
Site JP81011 Kitaadachi-Gun Saitama Japan Details
Site JP81006 Nagaizumi Shizuoka Japan Details
Site JP81003 Chuo Tokyo Japan Details
Site JP81002 Koto Tokyo Japan Details
Site JP81010 Okayama Japan Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field